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Pemphigus vulgaris antigen is in the cadherin supergene 
family. We hypothesized that the extracellular domain of 
pemp?igus vulgaris antigen might med~ate homophilic cell 
adheslOn because 1) the ongmally descnbed cadherins (e.g., 
E-cadherin) mediate this type of adhesion, 2) pemphigus 
vulgaris antigen is localized in desmosomes that are cell ad-
hesion junctions, and 3) autoantibodies in pemphigus vul-
garis patients cause loss of cell adhesion. To test this hypoth-
esis we used a system developed for E-cadherin that, when 
transfected into L cells (mouse fibroblasts), has been shown to 
cause aggregation. Because this aggregation requires the cy-
toplasmic domain ofE-cadherin to bind to catenins, we made 
a chimeric cDNA construct that encodes the extracellular 
domain of pemphigus vulgaris antigen and the cytoplasmic 
domain of E-cadherin. Analysis by immunofluorescence and 
flow cytometry with pemphigus vulgaris sera indicated that 
the pemphigus vulgaris antigen extracellular domain of this 
Pemphigus vulgaris is a skin disease in which autoanti-bodies cause loss of epidermal cell-to-cell adhesion with resultant blister formation [1]. Cloning of the cDNA encoding pemphigus vulgaris antigen (PVA) with auto-. antibodies from these patients revealed that it is a mem-
ber of the cadherin supergene family [2]. The originally described or 
classical cadherins (e.g., E-cadherin, N-cadherin, P-cadherin) have 
been shown to be calcium-dependent homophilic adhesion mole-
cules [3]. However, PYA is actually more closely related to the 
desmogleins, which are also in the cadherin supergene family, than 
to the classical cadherins [2,4] . Desmoglein was originally defined 
as a transmembrane glycoprotein found in the desmosome, a cell-
to-cell adhesion junction [4]. At least two genes encode desmogleins 
CDSG 1 and DSG2); the PYA gene is now termed DSG3, and, simi-
larly, PYA is also called desmoglein 3 [5,6]. Furthermore, PVA,like 
the other desmogleins, has been shown to be localized in desmo-
somes [7]. Although in the cadherin supergene family, desmogleins 
have not been shown to mediate homophilic adhesion. 
We hypothesized that PYA could mediate homophilic cell-to-
cell adhesion based on the findings discussed above, namely, 1) in 
pemphigus vulgaris patients autoantibodies against PYA cause loss 
of adhesion [8]. 2) PYA is closely related to classical cadherins both 
in overall amino acid sequence and in specific sequences that are 
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chimeric molecule (PVEC) was expressed on the cell surface 
of transiently transfected cells and permanently transfected 
L-cell clones. Immunoprecipitation of the chimeric molecule 
from extracts of these clones showed that the E-cadherin 
cytoplasmic domain bound catenins. Surprisingly, these L-
cell clones displayed only slight aggregation compared to an 
L-cell clone transfected with E-cadherin. This weak aggre-
gation was, however, specific and homophilic, as determined 
by cell sorting of only PVEC transfectants into aggregates 
from mixtures ofPVEC and neomycin resistance gene trans-
fectants, one of which was labeled with a fluorescent dye. We 
conclude that the extracellular domain of pemphigus vul-
garis antigen mediates weak homophilic adhesion and is not 
interchangeable in function with the extracellular domain of 
E-cadherin. Key words: desmosome/cadherin/autoimmul1e/ca-
tel1in . ] Invest Dermatol1 02:402 - 408, 1994 
putative functional sites in adhesion and calcium-binding [2], and 3) 
PYA is found in cell adhesion junctions [7]. 
Classical cadherins have been shown to mediate cell adhesion by 
transfection of their eDNA into L cells that are mouse fibroblasts 
that do not normally express cadherins [9 -11]. However, to medi-
ate cell adhesion the cytoplasmic domain of these cadherins must be 
intact. Even when the extracellular domain of cadherins is expressed 
on the cell surface it does not mediate adhesion if the cytoplasmic 
domain is severely truncated [12,13]. The cytoplasmic domain of 
cadherin binds to the actin cytoskeleton through molecules called 
catenins [13,14]. a-, /1-, and y-catenins are present in L cells and 
presumably permit the cadherins to function properly, perhaps by 
clustering the molecules in intercellular contact sites associated with 
the actin cytoskeleton [12,13,15]. In this regard a-catenin seems to 
be the key linking molecule, although /1-catenin is bound most 
tightly to the cadherin [13,15]. Studies of L cells transfected with 
cDNAs altered by site-directed mutagenesis of the intracellular re-
gion ofE-cadherin show that only those constructs capable of bind-
ing both a - and /1-catenin, or perhaps /J-catenin alone, function in 
homophilic adhesion, suggesting that this cytoplasmic binding is 
necessary for function [13,16]. a-catenin, on the other hand, is the 
most loosely associated with the cadherin-catenin complex and is 
sometimes difficult to detect [13,15]. Its importance in cadherin 
function is uncertain. 
The cytoplasmic tail of PV A, like the other desmogleins, binds 
only to plakoglobin (which co-migrates on sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) with a-catenin, 
but is probably a distinct protein [17,18]) and does not bind to a- or 
/1-catenin [19]. Thus, the cytoplasmic tail of PYA might not func-
tion in L cells. Therefore, to test the possible adhesive function of 
the extracellular domain of PV A we transfected L cells with a chi-
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Figure 1. Construction of chimeric cDNA that encodes the extracellular 
domain of PV A and the transmembrane and cytoplasmic domains of E-cad-
herin. The NotI-DraB restriction enzyme fragment of PYA cDNA was 
ligated to a PCR product that spanned the coding region for the E-cadherin 
(E-cad) transmembrane and cytoplasmic domain. A Drall restriction site was 
added to the upstream PCR primer and an XbaI site to the downstream 
primer. The ligated product was then cloned into the eukaryotic expression 
vector pcDNA 1 at a NotI-XbaI site. Hatched box and solid box indicate se-
quences encoding transmembrane regions. 
meric cDNA encoding the extracellular domain of PYA and the 
cytoplasmic domain of E-cadherin, which is known to function in 
these cells. We speculated that this binding of (X- and p-catenin by 
the cytoplasmic tail of the chimeric molecule (called PVEC) might 
be necessary for the extracellular domain of PV A to function prop-
erly . We show here that, although the PV A extracellular domain is 
expressed on the cell surface of the transfected L cells and the PVEC 
cytoplasmic domain binds catenins in the same way as the cytoplas-
mic domain of E-cadherin, PVEC mediates only weak homophilic 
binding when compared to that due to E-cadherin. 
MATERIALS AND METHODS 
cDNA Constructs The nucleotide sequence and numbering of the PYA 
cDNA and E-cadherin cDNA are as published [2,9]. Eukaryotic expression 
vectors, driven by the p-actin promoter, with cDNA encoding neomycin 
res istance (pBATneo) or mouse E-cadherin (pBATEM2) were provided by 
Masatoshi Takeichi [11]. PV cDNA containing the fuIl-Iength coding se-
quence was obtained by joining the previously cloned 5' PV cDNA (E33) 
with the previously cloned 3' PYA cDNA (EI2) at a common XbaI site at 
nucleotide 1085 [2,8]. The chimeric cDNA (called PVEC cDNA), encoding 
the extracellular domain of PYA and the transmembrane plus cytoplasmic 
region of E-cadherin was constructed as shown in Fig 1. The Not!-DraB 
fragment of the PYA cDNA was ligated to a Draii site engineered into a 
polymerase chain reaction (PCR) product of the E-cadherin cDNA. This 
PCR product was amplified with primers that spanned the nucleotides en-
coding the transmembrane region and cytoplasmic domain of E-cadherin. 
The PVEC chimeric cDNA was then directionally subcloned into the CMV 
promoter-driven eukaryotic expression vector pcDNAI (Invitrogen Corp., 
San Diego, CAl in a Not!-Xbal site. Nucleotide sequences of this construct 
revealed cwo mutations, one at nucleotide 397 of the PV A coding sequence 
and one at nucleotide 2396 of the E-cadherin coding region. Both of these 
mutations terminated the open reading frame, therefore they were replaced. 
The former was corrected with a PCR product of non-mutated PYA cDNA 
from the 5' Not! site to a Sall site at nucleotide 426. The latter was replaced 
with an XmaI-BpHI fragment from the E-cadherin cDNA. The final con-
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struct was totally sequenced and shown to have only one base change (a G to 
an A at position 2483 of the ch imeric construct) that did not change the 
amino acid sequence. 
Transient and Permanent Transfections COS-7 cells and L cells 
(ATCC CCL 1.1) were obtained from American Type Culture Collection 
(Rockville, MD). To determine if the chimeric PVEC protein was trans-
ported to, and expressed on, the cell surface, we transiently transfected 
COS-7 and L cells with Lipofectin (GIBCO-BRL, Gaithersburg, MD) ac-
cording to the manufacturer's directions. Approximately 5 ttg of the chi-
meric PVEC cDNA construct in pcDNAI was used per 6 cm dish of cells. 
To obtain permanent L-cell transfectants we used Lipofectin or calcium 
phosphate transfection systems (GIBCO-BRL) with 5-15 ttg of PVEC 
cDNA in pcDNA1 or E-cadherin cDNA construct pBATEM2 with 0.5ttg 
of pBATneo in 6 cm dishes. Two days after transfection cells were cultured 
in 400 ttg/rnl of G418 (GIBCO-BRL). After 10-12 d individual G418-re-
sistant colonies were selected with cloning rings. 
Immunologic Characterization ofTransfected Cells PV and bullous 
pemphigoid s~ra were obtained fron; p~tiellts with clinically, histologically, 
and Immnnohlstologlcally charactensnc disease. ECCD-2, a rat monoclonal 
IgG against mouse E-cadherin [20], was a gift from Masatoshi T akeichi, as 
was PCD-1, a rat monoclonal IgG against P-cadherin, used as a control [21]. 
To detect the extracellular domain of PYA on the surface of transiently 
transfected COS-7 and L cells, we performed immunofluorescence with PV 
sera. (or normal c?ntrol sera) and. ~uorescein isothiocyanate (FITC) -
conjugated goat anti-human IgG onllVlng cells as previously described [22]. 
We also analyzed permanently transfected L cell clones by flow cytometry. 
Single cell suspensions were prepared with 1 ruM ethylenediaminetetraace-
tic acid (EDTA) in 10 ruM Hepes-buffered calcium- and magnesium-free 
Hanks' balance~ salt solution (GIBCO-BRL). 2 X volume of washing buffer 
(10% fetal bovme serum, 1 ruM CaCI2, 0.02% sodium azide in Hepes-buf-
fered Hanks' solution) with 10 Jlg/ml deoxyribonuclease I (GIBCO-BRL) 
was added and cells were suspended at 5 X 105/200 ttl in washing bnffer. All 
subsequent washes and antibody incubations were performed at 4 ° C. Cells 
were incubated for 60 min in 20 JlI of a 1 :20 to 1 :50 dilntion (in washing 
buffer) of pemphigus vulgaris, bullous pemphigoid, or normal sera; washed 
cwice; and incubated for 30 min with 20JlI of a 1:40 dilution ofFITC-conju-
gated F(ab'), goat anti-human IgG (Tago, Burlingame, CAl. Cells were 
washed three times, re-suspended in 1 ml washing buffer containing 10 
ttg/ml deoxyribonuclease I for analysis on a FACScan flow cytometer (Bec-
ton Dickinson). Pro~idium iodide-permeable dead cells were gated out. 
To detect syntheSIS of the PVEC chimeric molecule we used immuno-
blotting of SDS extracts of transfected L cell clones [2]. Extracts of HACA T 
cells (a spontaneously. transformed human keratinocyteJine kindly provided 
by Dr. Norbert Fusemg) were used as a positive control for detection ofPV A. 
To demonstrate the binding of the cytoplasmic domain of E-cadherin to 
catenins, we metabolically labeled transfected L-cell clones with 35S-meth-
ionine/cysteine (NEN Express, Dupont, Boston, MA) for 18 h [7]. Radiola-
belled cells were extracted with 1 % Nonidet P-40, 1 % Triton X-I00, 2 mM 
CaCI2, 150 rnM NaCI in 10 mM Tris-HCI, pH 7.4, with protease inhibitors 
(aprotinin 2 ttg/ml, leupeptin 2 ttg/ml , pepstatin 1 jig/mi. PMSF 1 ruM). 
Aliquots of cell lysates containing approximately 60 X 106 cpm were preab-
sorbed With normal human serum (for immunoprecipitates performed with 
PV sera) Or normal rat serum (for immunoprecipitates performed with 
ECCD-2) and protein G sepharose (Sigma Chemical Co., St. Louis, MO), 
then precipitated with 10 ttl ofPV serum (or bullous pemphigoid serum used 
as a control) or ECCD-2, approximately 10 Jig (or PCD-l used as a control), 
and protein G, as previously described [7]. Immunoprecipitates were eluted 
from protein G with SDS sample buffer and resolved by SDS-PAGE [7]. 
Aggregation Assay Single ce ll suspensions of transfected L-cell clones 
were obtained with EDTA as described above. Cells were then washed twice 
in Hepes-buffered Hanks' solution with 10 Jig/ml deoxyribonuclease I and 
10% FBS in the first wash. Cells were re-suspended in Hepes-buffered 
Hank's solution with 10 ttg/ml deoxyribonuclease I and 1 ruM CaCI2. In 
some experiments 1 % bovine serum albumin, 10% fetal bovine serum, 2 
111M MgCI2 , or excess ethylene glycol bis-(fJ-aminoethyl ether) 
N ,N.N'-tetraacetic acid (EGTA) was added. Approximately 5 X 105 cells 
per 2.5 111.1 Were incubated in 35 mm dishes (precoated with 2% bovine serum 
albumin at 37°C for 2 h) with gentle shaking (approximately one revolution 
per secend) at 37° for 1 to 3.5 h, then incubated at room temperature without 
shaking for up to 24 h before being viewed with an inverted phase-contrast 
microscope. In some experiments we assessed the ability of two different 
transfected clones to self-aggregate (i .e. , sort) by labeling one with the 
fluorescent dye 5-carboxyfluorescein diacetate (Molecular Probes, Eugene, 
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Figure 2. Cell surface expression ofPVA on PVEC transfectants. Immuno-
fluorescence with PV sera demonstrates cell surface staining of a subpopula-
tion of COS-7 (A) and L cells (B) transiently transfected with PVEC 
eDNA. Sca le bar, 25 J.lm (A), 40 J.lm (B) . 
OR) at a concentration of 10-12.5 J.lM at room temperature for 10 min 
(from a stock solution of 10 mM in dimethylsulfoxide). 
RESULTS 
Characterization of the Chimeric PVEC cDNA Construct 
A chimeric eDNA encoding the extracellular domain of PV A and 
the transmembrane and cytoplasmic region of E-cadherin was con-
structed using a NotI-DraII restriction fragment of the PYA eDNA 
and a PCR product that spanned the nucleotides encoding the trans-
membrane region and cytoplasmic domain of E-cadherin (Fig 1). 
This product was cloned into pcDNA1, a eukaryotic expression 
vector driven by a CMV promoter. 
To demonstrate that this construct could be successfully tran-
scribed and translated in eukaryotic cells and that the protein prod-
uct could be expressed on the cell surface in the proper 0E-entation, 
we transiently transfected COS-7 cells and stained living cells by 
immunofluorescence with pemphigus vulgaris sera. Approximately 
5% of cells showed cell surface staining with five of five pemphigus 
vul garis sera, demonstrating that the PVEC protein is transported to 
the cell membrane with the PV A extracellular domain exposed (Fig 
2A). Similar staining was not seen with five bullous pemphigoid 
sera and one normal human serum. In addition, COS-7 cells trans-
fected with a PVEC construct that had a stop codon at nucleotide 
397 did not stain with PV sera. Because we wanted to use the PVEC 
construct for permanent transfection of L cells, we performed simi-
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Figure 3. PVEC clones express the chimeric protein. Immunoblots of ex-
tracts ofL-cell clones PVEC32, PVECll, neopl, and neopz with PV serum 
show that the clones transfected with the PVEC cDNA (PVEC32 and 
PVECll) express the chimeric protein (arrow) . For comparison is an extract 
of HACAT cells (H) which show the 130-kD PYA. 
lar immunofluorescence studies on L-cell transient transfectants 
with similar results (Fig 2B). 
Characterization ofPermanentiy Transfected L-Cell Clones 
L cells, which are mouse fibroblasts lacking cadherins, were co-
transfected with pBATneo (encoding for neomycin resistance) plus 
eukaryotic expression vectors containing either the PVEC construct 
or an E-cadherin construct (pBATEM2). Transfected clones were 
selected in G418. 
Immunoblotting of extracts of PVEC cDNA-transfected clones 
was performed to determine which clones synthesized PVEC pro-
tein. In some clones, PV sera detected a specific band of the expected 
molecular weight (approximately 120 kD), less than that of PYA 
itself (approximately 130 kD) because of the shorter cytoplasmic 
tail (Fig 3). Extracts of control clones transfected with pBATneo 
alone did not show staining of this band with PV sera. Two clones, 
PVEC11 and PVEC32, were selected for further characterization 
because they showed the largest amounts of the chimeric molecule 
on these immunoblots. 
To demonstrate that the extracellular domain of PYA was ex-
pressed on the cell surface of these clones, we used flow cytometric 
analysis with PV sera. PVEC cDNA-transfected clones PVEC11 
and PVEC32, but not clones transfected only with pBATneo 
(clones neop1 and neop2), showed cell surface fluorescence with PV 
sera, but not control bullous pemphigoid sera (Fig 4) . PVEC11 and 
PVEC32 showed approximately equal amounts of cell surface fluo-
rescence, consistent with the immunoblotting data. An L-cell clone 
(LECS) transfected with a eukaryotic expression vector encoding 
mouse E-cadherin (PBATEM2) also showed cell surface staining 
with ECCD-2, an anti-mouse E-cadherin monoclonal antibody, but 
not with a control monoclonal antibody, by flow-cytometric analy-
sis (data not shown; [23]). 
To demonstrate that the cytoplasmic domain of E-cadherin re-
tained the ability to bind catenins in the context of the PVEC chi-
meric molecule, we metabolically labeled PVEC11 and PVEC32 
and used PV sera for immunoprecipitation analysis. These studies 
demonstrated that the catenins were co-precipitated with the chi-
meric PVEC molecule (Fig 5). These co-precipitated eaten ins co-
migrated with the catenins co-precipitated with fu ll length E-cad-
herin from LEC5 cells (Fig 5). 
In addition, approximately equal amounts of radiolabeled caten-
ins were co-precipitated from extracts of both PVEC clones and the 
LECS clone. (Sequential immunoprecipitation analysis indicated 
that the first immunoprecipitate contained essentially all the pre-
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Figure 4. Extracellular PYA domain is expressed on the cell surface of 
L-ceJl clones transfected with the PVEC chimeric eDNA. PV sera and 
bullous pemphigoid (BP) control sera were used for flow-cytometric analy-
sis of clones PVECII. PVEC32. and control clones ncopl and neopz. 
cipitable material [data not shown]). These results indicate that ap-
proximately the same molar amount of catenin-bound PVEC mole-
cules and E-cadherin were expressed in the PVEC cells and the 
LEC5 cells, respectively, because the cytoplasmic domain ofE-cad-
herin binds catenins in a fixed molar ratio [15] . 
In sum, these data demonstrate that PVEC clones express the 
chimeric PVEC molecule in the proper orientation and that the 
cytoplasmic domain is functionally equivalent to that present in 
LEC5 cells. We, therefore, used these clones to compa.re the aggre-
gation potential of PVEC transfectants to that of E-cadherin 
PV PV uE B P PV uP 
11 32 LEC 32 ~2 LEC 
Figure 5. E-cadherin cytoplasmic domain in thc PVEC chimeric molecule 
binds to catenins. Extracts of clones PVECll (11), PVEC32 (32), LECS 
(LEC) , and control clone neopz (P2) were subjected to immunoprecipitation 
with pemphigus vulgaris (PV) serum, bullous pemphigoid serum (BP) as a 
control, ECCD-2 anti -E-cadherin antibody (all), and/or PCD-l anti -P-
cadherin antibody (aP) as a control. A rrow, E-cadherin; broke" arrow, PVEC 
chilTleric molecule; closed arrowhead, a-catenin; ope" arrowhead, p-catenin. 
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transfectants. This would be expected to provide a direct compari-
son of the PYA extracellular domain and the E-cadherin extracellu-
lar domain in which both have the same cytoplasmic domain that is 
capable of binding catenins. 
PVA Extracellular Domain Mediates Weak Homophilic 
Adhesion The ITlOrphology of the PVEC transfectants was no 
different from that of the neomycin-resistance transfectants or un-
transfected L cells. In contrast, the E-cadherin transfectant clone 
(LEC5) showed a more epithelioid morphology as has been previ-
ously reported [9]. 
In our first attempts at assaying the aggregation potential of 
transfe~ted L cells, we ~sed conditions developed for E-cadherin 
[11] . 0 Smgle . cell suspenSIons of transfected L cells, prepared with 
O.O~ Vo tryps.m/l mM CaC:l.2' were allowed to re-aggregate inl mM 
calcI~m. '!' Ith these cond~tlOns, E-cadherin is not degraded and will 
functIon m cell aggre~atlOn; however, we saw no aggregation of 
PVEC tr~nsfecta.nts (FIg 6A).S~bs~quent1y we determined by flow 
cyt,?metnc and ImmunopreClpltatlOn analysis that, unlike E-cad-
henn, the extracellular domain of PV A, both on PVEC transfec-
tants and keratinocytes, is degraded by trypsin/calcium treatment 
(unpublished observations). 
We therefore modified the c~nd~tions .of the aggregation assay to 
remove cells from. the culture dl~~ 111tO smgle cell suspensions with 
1 mM EDTA. W ith these condltlOns, PVEC transfectants still ex-
pr~sse~ PV A on the surface as determined by flow-cytometric anal-
YSIS .(Flg 4). When thes~ cells were allowed to re-aggregate in 1 mM 
calcIUm we observed shght aggregation of PVEC11 and PVEC32 
compared to very marked aggregation of LECS cells and little if 
any, aggregation of neop1 and neofJ2 cells (Fig 6). Although it ~as 
our general Impression from microscopic examination of cell aggre-
gates in 11 experiments that a subset of the PVEC11 and PVEC32 
cells aggregated, the aggreg~tion was too slight to be quantitated 
because most cells were not 111volved. In addition, the PVEC cell 
aggregates were loose with the individual cells well outlined com-
pared to the very compact aggregates of LECS cells that had lost 
thei~ cell ou~lines (Fig 6, compare C to B, D, and E). We tried 
vary111g condItions to enhance the aggregation. After detachment of 
cells we incubated with gentle shaking at 3rc from 1 h to 3.S h 
then incubated cells without sh~king at room temperature for up t~ 
24 h. We found that aggregatIon could be seen best either after 
!ncubat!on at 3rc for over 2 h or after the room temperature 
111~uba.tlOn for at least 1 h . However, under all conditions only a 
m1110nty <?f the cells formed aggregates. Aggregation seemed some-
what calcIUm dependent, as less aggregation was seen when cells 
were incubated in the presence of EGT A (data not shown) . 
To confirm that this aggregation of a subset of the PVEC trans-
fectallts was related to the expression of the PV A extracellular do-
main we determined if it represented homophilic adhesion by doing 
cell-sorting experiments in which two different transfectants were 
mixed, one of which was labeled with a fluorescent dye. In mixtures 
o.f LECS and PVEC cells, the LECS cells showed strong aggrega-
tIOn .and excluded the PVEC cells, demonstrating that E-cadherin 
medIates strong homophilic adhesion ofLECS cells and that other 
cells do not beco.me non-specifically incorporated into aggregates 
(Fig 7 A,B). In mixtures of PVEC cells alone, in which half of the 
cel ls were labeled, aggregates showed both labeled and unlabeled 
ce!ls, demonstrating that mixed aggregates could be detected with 
ti1lS method (Fig 7C,D). However, in mixtures of PVEC cells and 
neop cells, the small , sporadic aggregates that formed consisted 
e.ssentially only ofP~EC cells, showing that although the aggrega-
tion seen was weak It was specific for PV A expressing cells (Fig 
7E,F). 
DISCUSSION 
This study examines a direct comparison of the aggregation poten-
tial of the extracellu lar domains of PYA and E-cadherin when both 
are expressed in L cells and linked to the cytoplasmic catenins with 
the same (E-cadherin - derived) transmembrane and cytoplasmic 
domains. T he results show that the extracellular domain of PYA 
406 AMAGAI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
c 
Figure 6. Aggregation assay of transfectcd L-cell clones. Except for A, cells were released from the culture dish with EDTA. A/B and C/D/B/F, respectively, 
were aggregated under the same conditions at the same time. A) PVEC11 clone released from the substrate with 0.01 % trypsin/1 mM CaCl2 does not show 
aggregation at 1 h. B) PVEC11 clone released from the substrate with EDTA shows slight aggregation. C) LEC5 clone (transfected with E-cadherin) shows 
massive aggregation at 3.5 h. Note that cell borders are completely obscured. D) PVEC11 clone shows slight aggregation. B) PVEC32 clone shows slight 
aggregation. F) neo{12 clone (transfected with only a neomycin.!:.esistance gene) does not show aggregation. Scale bar, 125 ).lm. 
mediates weak, but specific and homophilic, adhesion that is not 
nearly as effective as adhesionl11ediated by E-cadherin. Only a small 
subpopulation of cells expressing PV A aggregated, and those that 
did showed rather loose clumping, very different from the large 
tight aggregates, in which cell borders are obscured, produced by 
LEeS cells. 
What could account for the weak aggregation of cells expressing 
the PYA extracellular domain compared to that ofE-cadherin? One 
possibiliry is that for cadherins to function properly they must bind 
the cytoskeleton. For E-cadherin this means that the cytoplasmic 
domain must bind actin filaments through its interaction with ca-
tenins [12] . To test the function of the PYA extracellular domain we 
expressed a chimeric molecule that had the cytoplasmic region of 
E-cadherin and we showed that this region functioned properly in 
the binding of catenins. If, as has been postulated, the cytoplasmic 
region of E-cadherin functions by clustering adhesion molecules 
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Figure 7. PVEC aggregation, although slight, is specific. A/B, C/D, and E/F, respectively, are phase and fluorescence views of the same fields. Each set of 
fields shows mixing of two different clones, one of which was labeled with a fluorescent dye. A/ B) LECS cells (unlabeled) and PVECll (labeled). Large 
aggregate of unlabeled cells do not incorporate labeled cells. C/D) PVECII (labeled) mixed with PVEC32 (unlabeled) show aggregates consisting of both 
labeled and unlabeled cells. E/F) PVEC32 (unlabeled) and neo/l2 (labeled). Note that small aggregates consist of unlabeled cells (i.e., PVEC32 cells without 
neofJ2 cells). Scale bar, 60 j.J.m. 
then the E-cadherin cytoplasmic region should have functioned 
properly in clustering the extracellular domain of PYA. On the 
other hand, if the cytoplasmic region functions by changing the 
conformation of the extracellular portion of E-cadherin, it might 
not function properly for the extracellular region of PV A. How-
ever, it is thought to be unlikely that the cytoplasmic domain of 
E-cadherin actually could effect its extracellular structure because 
lack of this domain does not change its biochemical properties that 
are presumably related to structure [12] . For the same reasons it is 
unlikely that the authentic PV A cytoplasmic tail would cause the 
extracellular domain ofPVA to function better. However this could 
not be tested directly because we have been unable to clone the 
full-length PYA eDNA due to mutations causing stop codons in the 
open reading frame whenever the full-length eDNA is cloned in 
bacteria (unpublished observation). 
Another possibility for minimal function ofPVA in this system is 
that its level in PVEC transfectants might be insufficient. This 
seems unlikely because immunoprecipitation experiments indicated 
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that the molar amounts of the catenin-bound PVEC chimeric mole-
cule in PVEC clones and E-cadherin in the LECS clone is about the 
same. In addition, multiple PVEC clones did not show marked 
aggregation. However, it is possible that the s~all amo~nt of agg;re-
gat ion we did see was due to those cells showmg particularly h1gh 
expression within each clone. 
Improper folding, glycosylation, and/or proteolytic processing 
of the precursor molecule to the mature form are also theoretically 
possible to account for the weak adhesive function of the PV A 
extracellular domain in these transfectants. For example, site di-
rected mutagenesis aimed at the proteolytic cleavage site of uvo-
morulin prevents its processing to the mature form and also destroys 
its adhesive function [24] . However, in general, mammalian cells 
fold and glycosylate proteins similarly. In addition, the classical 
cadherins are properly folded and processed to functional molecules 
in these L cells [9-11,24], therefore, it would be expected that PVEC 
would be similarly processed. Finally, PYA and classical cadherins 
have highly homologous proteolytic cleavage sites that are pre-
sumed to be processed by the same endogenous protease [2]. 
Another potential explanation for weak adhesion of PV A in this 
system is that our hypothesis that PV A functions in strong homo-
philic cell-to-cell adhesion might be incorrect. For instance, per-
haps PYA is involved instead in signal transduction when cells come 
together. However the observation that we did see weak and spe-
cific adhesion suggests that PV A does subserve this function, but we 
do not have the correct conditions for optimal function. 
We think the most likely reason that the extracellular domain of 
PV A did not function well in these tranfectants is that other mole-
cules, for example, other transmembrane and/or cytoplasmic des-
mosomal proteins, are necessary for proper function. It should also 
be considered that, ifPVA does function in adhesion, it may not be 
only by homophilic adhesion, but could conceivably bind also to 
another desmosomal transmembrane molecule. 
In any case we can conclude from these experiments that express-
ing the extracellular region of PV A on the cell surface is not suffi-
cient, in and of itself, to cause strong homophilic adhesion. The 
PV A extracellular domain does mediate weak homophilic adhesion 
and the direct comparison with E-cadherin suggests that the mecha-
nisms of homophilic interactions of PV A and E-cadherin are differ-
ent and may require different accessory molecules for maximal 
function. 
We thatlk Drs. Masatoslli Takeichi atld Norbert Fusetligfor providing antibodies 
and cells used ill these studies. 
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